Covered recipient · General Payments record
MARK C DAWSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,263.75
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.72 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $160.62 | 10 |
| GlaxoSmithKline, LLC. | $76.42 | 4 |
| Phathom Pharmaceuticals, Inc. | $47.87 | 2 |
| PFIZER INC. | $43.03 | 2 |
| Ardelyx, Inc. | $28.68 | 1 |
| Exact Sciences Corporation | $22.81 | 1 |
| Novo Nordisk AS | $17.42 | 1 |
| Merck Sharp & Dohme Corporation | $15.03 | 1 |
| Lilly USA, LLC | $13.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.02 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611556 | CMS |
| ABBVIE INC. | $4.44 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611558 | CMS |
| ABBVIE INC. | $28.47 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611560 | CMS |
| ABBVIE INC. | $21.46 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611562 | CMS |
| ABBVIE INC. | $9.06 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611564 | CMS |
| ABBVIE INC. | $14.27 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611566 | CMS |
| ABBVIE INC. | $19.26 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611568 | CMS |
| ABBVIE INC. | $15.09 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611570 | CMS |
| ABBVIE INC. | $21.04 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611572 | CMS |
| ABBVIE INC. | $11.51 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611574 | CMS |
| Ardelyx, Inc. | $28.68 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146677494 | CMS |
| Exact Sciences Corporation | $22.81 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114629300 | CMS |
| GlaxoSmithKline, LLC. | $20.46 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116133792 | CMS |
| GlaxoSmithKline, LLC. | $16.60 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116169475 | CMS |
| GlaxoSmithKline, LLC. | $16.74 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116292959 | CMS |
| GlaxoSmithKline, LLC. | $22.62 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116224736 | CMS |
| Lilly USA, LLC | $13.84 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135156815 | CMS |
| Merck Sharp & Dohme LLC | $15.03 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141601565 | CMS |
| Novo Nordisk Inc | $17.42 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096951616 | CMS |
| PFIZER INC. | $24.47 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131793729 | CMS |
| PFIZER INC. | $18.56 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131747870 | CMS |
| Phathom Pharmaceuticals, Inc. | $22.77 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151054265 | CMS |
| Phathom Pharmaceuticals, Inc. | $25.10 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151054267 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.